Tranexamic acid to prevent heavy bleeding after C-section
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant and plan a medically needed C-section after 34 weeks, or an elective C-section at 39 weeks
- Or you are expected to deliver vaginally after 34 weeks
- Your kidney function blood test is normal (creatinine under 0.9 within 2 weeks of your delivery date)
- You are age 18 to 50
- You can understand the study and sign consent forms
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a medicine called tranexamic acid before a cesarean section (c-section) can help reduce the amount of blood loss during the surgery. It may be an option for women having either a planned or unplanned c-section.
This trial tests whether giving a drug called tranexamic acid before a planned C-section can reduce the risk of severe bleeding after birth. It is for women who are otherwise healthy and expecting a single baby.
This study compares two ways to prevent heavy bleeding after a C-section. One uses a combination of three medicines, and the other uses a single medicine. The goal is to find which is safer and more effective at reducing blood loss.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
This trial tests whether giving tranexamic acid during a C-section can reduce the risk of heavy bleeding after childbirth. It may help women who have certain risk factors for postpartum hemorrhage.
This trial tests if a medicine called tranexamic acid can reduce the risk of heavy bleeding after a C-section for women who have certain autoimmune diseases. It aims to help prevent postpartum hemorrhage in this specific group.
Hear when a new Post Partum Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.